Search for: "Gray v. Brandt"
Results 1 - 2
of 2
Sorted by Relevance
|
Sort by Date
9 Mar 2020, 1:21 pm
FDA Draft Guidance for Industry: Promotional Labeling and Advertising Considerations for Prescription Biological Reference and Biosimilar Products Questions and Answers Catherine Gray, Staff Director, Office of Prescription Drug Promotion, CDER, FDAElizabeth Pepinsky, Health Science Policy Analyst, Office of Prescription Drug Promotion, CDER, FDA: Draft guidance issued by OPDP in consultation w/other groups focusing on biosimilars. [read post]
16 Sep 2009, 1:47 pm
(Charlestown, MA; Richard Gray, President) Blessed Travel Plus Inc. [read post]
